Omalizumab withdrawal outcomes in chronic spontaneous urticaria are linked with baseline IgE and eosinophil levels

Omalizumab withdrawal outcomes in chronic spontaneous urticaria are linked with baseline IgE and eosinophil levels

Background: Chronic Spontaneous Urticaria (CSU) is an immune-mediated skin disease that may require prolonged treatments. Currently, there are no recommendations for treatment discontinuation once CSU symptoms are controlled, particularly among patients primarily diagnosed with severe CSU. Objective...

Full description

Bibliographic Details
Main Authors: Ramit Maoz-Segal, MD, Guy Levenberg, B.MED.SC, Tanya Levy, MD, Soad Haj-Yahia, MD, Ronen Shavit, MD, Diti Machnes-Maayan, MD, Yulia Lifshitz -Tunitsky, MD, Stanely Niznik, MD, Irena Offengenden, MD, Mona Iancovich-Kidon, MD, Nancy Agmon-Levin, MD
Format: Article
Language:English
Published: Elsevier 2024-05-01
Series:World Allergy Organization Journal
Subjects:
Omalizumab
Chronic spontaneous urticaria
IgE
Eosinophil
Treatment withdrawal
Online Access:http://www.sciencedirect.com/science/article/pii/S193945512400036X

Internet

http://www.sciencedirect.com/science/article/pii/S193945512400036X

Similar Items